Treatment Noncompliance Level Among Patients with Type 2 Diabetes Mellitus: A Hospital Based Cross-Sectional Study in Bangladesh - Khan, Ishtiakul Islam; Pulock, Orindom Shing; Barua, Biddhuth; Dola, Taslima Ahmed; Chowdhury, Pratik; Seal, Tapan; Salekin, Sanzida; Quader, Md. Tarek Ul; Mitra, Ambarish; Chowdhury, M A Hassan; Siddiqui, Sayeda Rumman Aktar (medRxiv, 2022)
Introduction The consequence of good diabetic treatment depends on the patient’s commitment to a large degree. Noncompliance leads to inadequacy of metabolic control, which strengthens the advancement and speeds up diabetic complications.Methodology This descriptive cross-sectional study was conducted at Medical Center Hospital, Chattogram, Bangladesh. The study included two hundred and fifty-nine patients with T2DM. Data regarding sociodemographic factors, patient’s characteristics, medication factors, physician-related factors, and noncompliance were collected using a pretested and structured questionnaire. Treatment adherence was assessed by Morisky Medication Adherence Scales (MMAS-8). Data analyses were conducted on SPSS v23.0 Software. The study’s main goal was to assess the treatment noncompliance level among patients with type-2 diabetes mellitus (T2DM) in Bangladesh.Result The majority of the participants (56%) were in the 40-45 years of age group, followed by 32% in the older age group (>=60 years), and 62.5% of them were male. One hundred and sixty-eight (64.86%) patients were considered low adherent as per the response of the MMAS-8 scale (score <6), followed by 57 (22.0%) patients were regarded as high adherent (score 8) and 34 (13.13%) patients were considered medium adherent (score 6-7) to treatment. Observing the frequency distribution for noncompliance, financial concerns (32.3 %), forgetfulness (27.7%), a busy daily schedule (17.7%), and fear of antihyperglycemic drug side effects were all identified as significant explanations. On multivariate analysis, participants aged 60 years or more, monthly family incomes of <30,000BDT or 30,000 – 50,000 BDT, smoking, and uncontrolled glycemic status showed higher chances of noncompliance than their counterparts.Conclusion Patient counseling and awareness programs may enhance treatment adherence among people with T2DM. Our findings will help physicians and public health workers to develop targeted strategies to increase awareness of the same among their patients.HighlightsOne of the most preventable causes of treatment failure is noncompliance with treatment.Age group, educational level, and monthly family income had a significant association with the compliance to treatment in diabetic patientsMajority of the respondents (64.86%) were low adherent to the medications as per MMA-8 scale.Financial issues (32.3 percent), forgetfulness (27.7%), a hectic daily schedule (17.7%), and fear of antidiabetic medicine side effects were all cited as key causes for noncompliance with antidiabetic treatment.Aged participants (>= 60 years), monthly family income of (30,000-50,000) BDT, uncontrolled glycemic status and smokers portrayed higher frequency of noncompliance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of North South University, Dhaka, Bangladesh gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors BDTBangladeshi TakaBMIBody Mass IndexIPDIndoor Patient DepartmentHSCHigher School CertificateMMAS-8Morisky Medication Adherence ScalesNCDsNon-Communicable DiseasesOPDOutdoor Patient DepartmentRBSRandom Blood SugarSPSSStatistical Packages for Social SciencesT2DMType 2 Diabetes Mellitus